ABSTRACT OBJECTIVES This study sought to evaluate if diastolic pulmonary gradient (DPG) can predict survival in patients with pulmonary hypertension due to left heart disease (PH-LHD).
P atients with pulmonary hypertension (PH) due to left heart disease (PH-LHD), defined as pulmonary capillary wedge pressure (PCWP) >15 mm Hg and mean pulmonary artery pressure (mPAP) $25 mm Hg, have worse prognosis compared to those without PH (1) . Among those patients with PH, 2 phenotypes have been described: 1) a group of isolated post-capillary or "passive" PH in which elevated pulmonary pressures are reversible and in proportion to increases in left atrial pressure; and 2) a group with "pre-capillary" component (combined post-capillary and pre-capillary pulmonary hypertension [CpcPH] ) whose pulmonary hypertension is worse than can be fully explained by passive elevation secondary to elevated left atrial pressure. This latter group may have comorbid pulmonary vascular remodeling and therefore may demonstrate persistent PH after interventions to lower left-sided filling pressures. The ability to accurately define and separate a high-risk subgroup has major implications in the management and outcomes of heart failure patients as those with CpcPH due to left heart disease have worse prognosis (1,2) and may not be suitable for cardiac transplantation (2) .
In an effort to better characterize the 2 populations, several hemodynamic para- More recently diastolic pulmonary gradient (DPG), diastolic pulmonary artery pressure (dPAP) minus PCWP has been proposed to distinguish CpcPH from isolated post-capillary PH (3, 8) . Elevated DPG ($7 mm Hg) may be associated with pulmonary vascular remodeling and predict worse survival in individuals with elevated TPG and PH-LHD (9) . We have previously shown, however, that DPG is not associated with death after heart transplant, which may call into question the assertion that DPG is a strong marker of intrinsic pulmonary vascular disease in PH-LHD (10) . In this study, we sought to determine whether an elevated DPG predicted survival using a cohort of 1,236 patients previously evaluated for unexplained cardiomyopathy (5).
METHODS

PATIENTS. Study subjects included inpatients and outpatients referred to the Johns Hopkins Hospital
Cardiomyopathy Service for further evaluation of heart failure due to undiagnosed cardiomyopathy. All patients received treatment of their heart failure prior to undergoing right heart catheterization and biopsy.
A total of 1,236 patients were evaluated between December 1982 and December 1997 as previously described (11) . All patients underwent extensive work up, which included endomyocardial biopsy with right heart catheterization by a heart failure cardiologist and coronary angiography when indicated. After the evaluation, all patients were assigned a cause of cardiomyopathy. Age, gender, race, height, and weight were recorded at the time of their initial evaluation. The patients were followed until death, cardiac transplantation, or the end of the study period (January 1, 1998). Vital status was obtained from medical records and through a search of the Nation Death Index (12) . or $9 mm Hg) and low DPG groups (<1, <3, <5, <7, or <9 mm Hg) ( Table 2) . We further examined the cutoff of 7 mm Hg, which has previously been shown to be a surrogate marker for CpcPH (9) and has been proposed for clinical use (8) . Demographic, diagnostic and hemodynamic data for those subjects (DPG <7 and DPG $7 mm Hg) as well as the 650 patients without PH are presented in Table 3 . Demographic and heart failure diagnosis were similar between the high and low DPG groups. Compared with the lower DPG group (<7 mm Hg), patients with DPG $7 mm Hg had higher systemic and pulmonary artery pressures, Table 4 ).
In a subcohort of patients with TPG >12 mm Hg (n ¼ 151), higher DPG ($7 mm Hg) was not associated with increased mortality ( Figure 1B) . Figure 1C suggests that in subjects with PVR $3 mm Hg (n ¼ 179), those subjects with a low DPG (<7 mm Hg) trended toward worse Table 2 ).
DISCUSSION
In the present study, we used a well-characterized, 
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DPG Does Not Predict Survival in PH-LHD (4, 14) . Both of these factors depend on the flow (cardiac output) (3). The dPAP, however, is less sensitive to these effects, and therefore DPG (dPAP minus PCWP) has been recommended as an alternative and more reliable marker of PH-LHD with a pre-capillary component (8) .
The prognostic capability of DPG in patients with
CpcPH was recently evaluated in a cohort of 1,094 patients with PH-LHD. In this study by Gerges et al. open the possibility that DPG may have a prognostic ability in heart failure with preserved ejection fraction, or in a more select group of heart failure patients. Because the incidence of PH-LHD was relatively low in our population (44%), this could limit 
